New TGA advice for prescribing Roaccutane

The TGA has issued an important reminder to doctors prescribing isotretinoin to tread carefully following a UK report that suggests an association with psychiatric adverse events.

Isotretinoin, which is marketed in Australia as Roaccutane and multiple generics, is a retinoid that inhibits sebaceous gland function and keratinisation.

According to the TGA website, the UK Medicines and Healthcare Products Regulatory